Sham or no sham control: that is the question in trials of renal denervation for resistant hypertension. A systematic meta-analysis
Background: Studies of renal denervation (RDN) in patients with apparent treatment resistant hypertension have been hampered by a number of patient and physician related confounders on blood pressure (BP) including poor drug adherence. It remains uncertain whether RDN lowers BP. We aimed to investig...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-07-01
|
Series: | Blood Pressure |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/08037051.2017.1311769 |